Read more

February 06, 2025
61 min listen
Save

Live from Hawaiian Eye 2025

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA.

  • Welcome to the Eyeluminaries podcast :02
  • Review of episode 30 3:23
  • Intro of Paul Singh, MD 3:40
  • What are the future trends in glaucoma you’re most excited about? 5:10
  • What challenges do you see in running your practice that didn’t exist in your dad’s day? 8:36
  • You’ve got a great medical office, a very busy consulting and research practice, you play in a band and you have a young family. What advice would you give others in keeping it all in balance? 12:09
  • Besides your dad and the two of us, who do you look up to in eye care? 14:45
  • Singh sings a Funkadesi song 18:16
  • Intro of Candy Simerson 20:36
  • When you come into a new practice to consult, what are the most common areas you see where improvement can be made? 21:41
  • What about the finances? What areas in finances do you see where improvement can be made? 24:27
  • In your many years in ophthalmology, what are the biggest challenges you’ve experienced? 26:10
  • What type of practice should consider a sale to private equity? What type of practice should not? 29:34
  • What advice would you give a company representative who wants to win business from a big ophthalmology practice? 32:29
  • Intro of the Goldbergs 36:25
  • Jeff Goldberg, MD, PhD 36:50
  • Roger Goldberg, MD, MBA 37:21
  • Jeff, why glaucoma instead of retina? 38:43
  • Roger, why retina instead of glaucoma? 39:37
  • Mazzo discusses neuroprotection in retina and glaucoma. 41:14
  • What is entrepreneurship like today? What’s your advice? What is challenging and what is positive? 43:10
  • Mazzo discusses being realistic about innovations. 48:30
  • What is private practice like today? 49:31
  • How do cornea specialists better understand glaucoma specialists? 53:05
  • How do cornea specialists better understand retina specialists? 54:13
  • Tell us about emmecell. 55:50
  • Preview of episode 32 59:19
  • Give us your feedback 1:00:18
  • Thanks 1:00:30

Jeffrey Goldberg, MD, PhD, is professor and chair of ophthalmology at the Byers Eye Institute at Stanford University and a member of the National Academy of Medicine.

Roger Goldberg, MD, MBA, board certified by the American Board of Ophthalmology and is an active member of the American Society of Retinal Specialists, the Retina Society and the American Academy of Ophthalmology.

John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.

Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA.

Candy Simerson is the senior vice president of practice operations at Vision Integrated Partners.

I. Paul Singh, MD, is the president of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He is a founding member of the band, Funkadesi, a mix of Indo-Afro-Caribbean style music. The band tours the world spreading the message “one family, many children.”

We’d love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian.

Sources/Disclosures

Collapse

Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for the Goldbergs, Simerson and Singh at the time of publication.